MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Capital expenditures 2016–2024
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$218,000FY2024 · since FY2016: $76,179 → $218,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $218,000 | -75.6% |
| FY2023 | $892,000 | +243.1% |
| FY2022 | $260,000 | +4422.5% |
| FY2021 | $5,749 | -98.6% |
| FY2020 | $405,604 | -24.3% |
| FY2019 | $535,916 | -43.1% |
| FY2018 | $942,180 | — |
| FY2017 | $0 | -100.0% |
| FY2016 | $76,179 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice